Delivery Order SPE2DB22D1106-SPE2DB25FELR6

Award Date 5/2/25
Potential Completion Date 5/5/25
Potential Value $6.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,353.76 firm-fixed-price contract is for the delivery of CERVIDIL 10 MG vaginal inserts, with a period of performance through March 31, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a leading global pharmaceutical distributor, to supply CERVIDIL 10 MG vaginal inserts. The delivery order has a ceiling value of $8,673.52 and a period of performance through March 26, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of $999,999,999.00 and a performance period through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The order is for the medical product CERVIDIL 10 MG VAGINAL INSRTS, with a ceiling value of $2,707.52 and a performance period ending on April 29, 2025. The contract is not set aside and is a firm-fixed-price delivery order. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth $5,927.43 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of 4564858831 CERVIDIL 10 MG VAGINAL INSRTS, a pharmaceutical product, with a completion date of June 11, 2024. This award falls under Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $3,115.97 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of CERVIDIL 10 MG VAGINAL INSRTS. This delivery order is part of a larger indefinite delivery contract (IDC) between Amerisourcebergen Drug Corp and DLA, valued at up to $999,999,999.00 through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565798983 CERVIDIL 10 MG VAGINAL INSRTS, a pharmaceutical product, with a ceiling value of $2,495.76. The contract is a Firm Fixed Price contract type and has an ultimate completion date of September 16, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to...
The U.S. Defense Logistics Agency (DLA) awarded a $9,468.03 Firm Fixed Price Delivery Order contract to Amerisourcebergen Drug Corp. for the supply of CERVIDIL 10 MG VAGINAL INSRTS. This order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide....
This is a delivery order (SPE2DB22D1106|SPE2DB25FDSR0) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CERVIDIL 10 MG VAGINAL INSRTS. The award has a ceiling value of $4,061.28 and a completion date of January 3, 2025. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor, and the company holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,247.88 firm fixed-price delivery order is for the supply of CERVIDIL 10 MG VAGINAL INSRTS, a medical product used in obstetrics and gynecology. The contract has a ceiling value of $1,247.88 and an ultimate completion date of June 28, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery...
This contract award is for the delivery of CERVIDIL 10 MG VAGINAL INSRTS to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on August 29, 2022, with a ceiling value of $1,149.80. The contract has a completion date of August 30, 2022 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FELR6
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $6,768.80, is for the supply of CERVIDIL 10 MG VAGINAL INSRTS, a pharmaceutical product. The contract has an ultimate completion date of May 5, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This delivery order is part of that larger contract vehicle, enabling the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The contract is not set aside and was awarded through open competition.

Generated 8/3/25, 12:54 AM